期刊
NATURE CHEMICAL BIOLOGY
卷 12, 期 7, 页码 559-+出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/NCHEMBIO.2097
关键词
-
资金
- US National Institutes of Health (NIH) [K01MH091449, U01MH105027, R01AA022583, R44GM093456, T32EB009383, T32GM008284, R01MH086867, R21MH085205]
- Charles and Ann Sanders MGH Research Scholar Award
- Glenn Foundation Award for Research in Biological Mechanisms of Aging
Many psychiatric drugs act on multiple targets and therefore require screening assays that encompass a wide target space. With sufficiently rich phenotyping and a large sampling of compounds, it should be possible to identify compounds with desired mechanisms of action on the basis of behavioral profiles alone. Although zebrafish (Danio rerio) behavior has been used to rapidly identify neuroactive compounds, it is not clear what types of behavioral assays would be necessary to identify multitarget compounds such as antipsychotics. Here we developed a battery of behavioral assays in larval zebrafish to determine whether behavioral profiles can provide sufficient phenotypic resolution to identify and classify psychiatric drugs. Using the antipsychotic drug haloperidol as a test case, we found that behavioral profiles of haloperidol-treated zebrafish could be used to identify previously uncharacterized compounds with desired antipsychotic-like activities and multitarget mechanisms of action.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据